J. Margison

Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer

Sarah Danson, D. Ferry, Valery Yu. Alakhov et al. · British Journal of Cancer · 2004 · 377 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +14

Phase II study of SPI-77 (sterically stabilised liposomal cisplatin) in advanced non-small-cell lung cancer

Stuart C. White, Paul Lorigan, Geoffrey P. Margison et al. · British Journal of Cancer · 2006 · 150 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Methylated purines in the deoxyribonucleic acid of various Syrian-golden-hamster tissues after administration of a hepatocarcinogenic dose of dimethylnitrosamine

Geoffrey P. Margison, J. Margison, Ruggero Montesano · Biochemical Journal · 1976 · 98 citations · Full text

Medicine, Biochemistry, Carcinogenesis +9

Prolongation of ifosfamide elimination half-life in obese patients due to altered drug distribution

Michael Lind, J. Margison, T. Cerny et al. · Cancer Chemotherapy and Pharmacology · 1989 · 66 citations

Medicine, Pharmacokinetics, Pharmacology +8

Some aspects of metabolic activation of chemical carcinogens in relation to their organ specificity

Helmut Bartsch, Geoffrey P. Margison, C. Malaveille et al. · Archives of Toxicology · 1977 · 43 citations

Medicine, Biochemistry, Toxicology +16